- Associate Professor, CWRU School of Medicine
- Assistant Professor, CWRU School of Medicine
Asim Shahid, MD is the Division of Child Neurology and Epilepsy Chief at University Hospitals Rainbow Babies & Children's Hospital and an associate professor of pediatrics. He is also the Pediatric Epilepsy Monitoring Unit Director. His primary focus is on pediatric epilepsy, electroencephalography, and medically intractable epilepsies, requiring both medical and surgical management.
Dr. Shahid is an active member of multiple national societies and multinational foundations. He established a Tuberous Sclerosis Clinic, a part of the Tuberous Sclerosis Alliance in 2018, and serves as the program's medical director. Dr. Shahid's research interests include new treatment options for Dravet and Lennox-Gastaut syndromes.
Dr. Shahid graduated from Universidad Iberoamericana, followed by a pediatric residency at Morristown Memorial Hospital in Morristown, New Jersey. He received his pediatric neurology training at Rainbow Babies and Children's Hospital, University Hospitals of Cleveland, and completed a fellowship in clinical neurophysiology, epilepsy track at University Hospitals of Cleveland.
- Dravet syndrome
- Electroencephalography (EEG)
- Epilepsy Surgery Evaluation
- Pediatric Epilepsy
- Pediatric Neurology
English, Punjabi, Urdu
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland OH, 44106
UH North Ridgeville Health Center
32800 Lorain Rd
North Ridgeville OH, 44039
- Epilepsy - American Board of Psychiatry and Neurology
- Neurology with Special Qualifications in Child Neurology - American Board of Psychiatry and Neurology
Fellowship | Clinical Neurophysiology
Clinical Neurophysiology - Uh Case Medical Center (2008 - 2009)
Fellowship | Pediatric Neurology
Pediatric Neurology - Uh Case Medical Center (2005 - 2008)
Residency | Pediatrics
Pediatrics - Morristown Memorial Hospital (2002 - 2005)
Universidad Iberoamericana (2001)
University Of Vermont (1996)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Asim Shahid did not disclose any Outside Relationships with Industry.